
Oginan 50 Injection
Marketer
Logimed Pharma Pvt Ltd
Salt Composition
Nandrolone Decanoate (50mg)
Overview Oginan 50 Injection
Postmenopausal osteoporosis is treated with Oginan 50 Injection, a medication that strengthens weakened, fragile bones. Administration is exclusively by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined solely by your physician, and consistent use is crucial for optimal results. Discontinuation should only occur under medical supervision; do not cease treatment upon feeling improved. Common side effects include edema (leg, ankle, and foot swelling), fluid retention, nausea, vomiting, acne, and breast enlargement. Report any bothersome side effects to your doctor immediately. Prior to treatment, disclose any kidney or liver conditions, and provide a complete list of all medications currently being taken. Pregnant or breastfeeding individuals must consult their doctor before using Oginan 50 Injection.
Primary Ingredients of Oginan 50 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Oginan 50 Injection
Managing Osteoporosis After Menopause
Major Benefits of Oginan 50 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
Common Side effects of Oginan 50 Injection:
- Edema (swelling)
- Nausea
- Breast enlargement
- Acne
- Vomiting
How to use Oginan 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Oginan 50 Injection works:
Oginan 50 Injection, an anabolic steroid, replicates the actions of testosterone, the primary male hormone. Its mechanism involves bolstering bone density in patients experiencing the fragility associated with osteoporosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oginan 50 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Oginan 50 Injection during pregnancy carries substantial risk. Pregnant women should consult their physician; research in animal and human studies indicates significant potential harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Oginan 50 Injection with breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Oginan 50 Injection.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Oginan 50 Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Patients with hepatic impairment should use Oginan 50 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Oginan 50 Injection :
Should you forget a dose of Oginan 50 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oginan 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Anabolic-androgenic steroid |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
